As part of an initiative aimed to share best practices in Medicinal Chemistry, the European Federation for Medicinal Chemistry (EFMC) is preparing a series of webinars and slide sets focused on the early phase of drug discovery. This educational material is freely accessible through the EFMC. The main target audiences are students or early career scientists and we also believe it will be valuable for experienced practitioners. The first of the series is focused on the generation and validation of high-quality chemical probes, which are critical for drug discovery and more broadly to further our understanding of human biology and disease
Background—High attrition rates in drug discovery call for new approaches to improve target validati...
Introduction: The rational development of new therapeutics requires a thorough understanding of how ...
The identification of high-quality starting points for drug discovery is an enduring challenge in me...
As part of an initiative aimed to share best practices in Medicinal Chemistry, the European Federati...
Ground-breaking research in disease biology and continuous efforts in method development have uncove...
Phenotypic drug discovery has a long track record of delivering innovative drugs and has received re...
: Hit generation is a crucial step in drug discovery that will determine the speed and chance of suc...
A reflection on the development of medicinal chemistry and chemical biology in Europe, and how the E...
Abstract: The European Federation for Medicinal chemistry and Chemical biology (EFMC) is a federatio...
The European Federation for Medicinal chemistry and Chemical biology (EFMC) is a federation of learn...
Drug discovery encompasses processes ranging from target selection and validation to the selection o...
Successful drug research depends on adequate links between therapeutic benefits for the treatment of...
Successful drug research depends on adequate links between therapeutic benefits for the treatment of...
The European Federation for Medicinal chemistry and Chemical biology (EFMC) is a federation of learn...
Potent, selective and broadly characterized small molecule modulators of protein function (chemical ...
Background—High attrition rates in drug discovery call for new approaches to improve target validati...
Introduction: The rational development of new therapeutics requires a thorough understanding of how ...
The identification of high-quality starting points for drug discovery is an enduring challenge in me...
As part of an initiative aimed to share best practices in Medicinal Chemistry, the European Federati...
Ground-breaking research in disease biology and continuous efforts in method development have uncove...
Phenotypic drug discovery has a long track record of delivering innovative drugs and has received re...
: Hit generation is a crucial step in drug discovery that will determine the speed and chance of suc...
A reflection on the development of medicinal chemistry and chemical biology in Europe, and how the E...
Abstract: The European Federation for Medicinal chemistry and Chemical biology (EFMC) is a federatio...
The European Federation for Medicinal chemistry and Chemical biology (EFMC) is a federation of learn...
Drug discovery encompasses processes ranging from target selection and validation to the selection o...
Successful drug research depends on adequate links between therapeutic benefits for the treatment of...
Successful drug research depends on adequate links between therapeutic benefits for the treatment of...
The European Federation for Medicinal chemistry and Chemical biology (EFMC) is a federation of learn...
Potent, selective and broadly characterized small molecule modulators of protein function (chemical ...
Background—High attrition rates in drug discovery call for new approaches to improve target validati...
Introduction: The rational development of new therapeutics requires a thorough understanding of how ...
The identification of high-quality starting points for drug discovery is an enduring challenge in me...